Meta description: Blumont Pharma Limited issues recall for Ocumont Eye Ointment due to missing Braille labeling on outer cartons. Published on 2026-01-27T22:02:47.000Z.
Blumont Pharma Limited has announced a recall of one batch of Ocumont Eye Ointment 1% w/w due to the absence of Braille information on the outer carton. This issue was identified during a routine inspection, and the company is taking immediate action to correct the problem. The recall affects prescription-only medication, and patients who use this product should be aware of the situation.
Navigation: What changed? | Who is affected? | FAQ | Conclusion | Disclaimer | Announcement Line
What changed?
The Braille information was inadvertently omitted from the outer carton of one batch of Ocumont Eye Ointment 1% w/w. This omission may cause difficulties for patients who rely on Braille labeling to identify their medication.
Why is Braille labeling important?
Braille labeling is crucial for patients with visual impairments, as it provides them with a way to identify their medication independently. The absence of Braille information on the outer carton may lead to medication errors or confusion.
Who is affected?
Patient who use Ocumont Eye Ointment 1% w/w and rely on Braille labeling are affected by this recall. Healthcare professionals and pharmacists should also be aware of the situation to ensure that patients receive the correct medication and instructions.
What should patients do?
Patients who use Ocumont Eye Ointment 1% w/w should contact their healthcare provider or pharmacist to confirm that they have the correct medication and instructions. They should also be aware of the potential risks associated with the missing Braille labeling.
FAQ
- What is the reason for the recall?
The recall is due to the absence of Braille information on the outer carton of one batch of Ocumont Eye Ointment 1% w/w. - Who is affected by the recall?
Patient who use Ocumont Eye Ointment 1% w/w and rely on Braille labeling are affected by this recall. - What should patients do?
Patients who use Ocumont Eye Ointment 1% w/w should contact their healthcare provider or pharmacist to confirm that they have the correct medication and instructions.
Conclusion
In conclusion, the recall of Ocumont Eye Ointment 1% w/w due to missing Braille labeling on outer cartons is a serious issue that affects patients with visual impairments. It is essential for patients, healthcare professionals, and pharmacists to be aware of the situation and take necessary actions to ensure that patients receive the correct medication and instructions.
Disclaimer
This article is not intended to provide legal advice. It is essential to consult with a qualified healthcare professional or regulatory expert for specific guidance on this matter.
For full information about the announcement, see the link below.
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-blumont-pharma-limited-ocumont-eye-ointment-1-percent-w-slash-w-el-26-a-slash-03